Stockreport

Bruker Introduces iNTApharma™, a Label-Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

Bruker Corporation  (BRKR) 
Last bruker corporation earnings: 10/31 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bruker.com/investors/default.aspx
PDF New iNTApharma system enables rapid, native-state size and concentration measurements with single-particle sensitivity for viral, vesicle, and nanoscale bioparticle work [Read more]